If you purchased or acquired securities in AstraZeneca between between February 23, 2022 and December 17, 2024 and would like ...

NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn ...

The boss of drugmaker AstraZeneca has said he was “very disappointed” with the firm’s move to scrap plans for a £450 million vaccine plant in Liverpool, but insisted the business case did not stack up ...

In particular, the charges have targeted two lawmakers typically seen as pharma foes: Sens. Bernie Sanders (I-Vt.) and ...

Recent health news covers significant events like Pfizer's diversity program settlement, AstraZeneca's halted UK investment, ...

The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, ...

Recent health news includes Pfizer settling a lawsuit about a diversity fellowship, a New York doctor indicted for prescribing abortion pills in Louisiana, AstraZeneca canceling UK investment, ...

Interest rates were lowered by a quarter of a point. Governor Andrew Bailey said there was "heightened uncertainty".

If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England.

Stock markets rose Thursday on easing trade tensions and some strong company earnings, with London hitting a record high.

Stock markets rose Thursday on easing trade tensions and thanks to some strong company earnings, analysts said.